Previous 10 | Next 10 |
home / stock / fujif / fujif news
The Biden administration is being pressured to suspend the intellectual property of companies that have developed the COVID-19 vaccine and antibody therapies. The intellectual property possessed by companies that helped them develop a COVID-19 vaccine as well as antibody therapies off...
We have assessed FUJIFILM's transition to date as a healthcare business. The conclusion is that they have made material progress, and the outlook is positive. The secular decline in office equipment business needs to be managed, but healthcare should continue to scale via M&A and ...
FUJIFILM Holdings (FUJIF) is planning to restart the clinical trials in April for its anti-viral therapy Avigan in Japan against COVID-19, Nikkei reported on Sunday.The double-blind, placebo-controlled trial with the participation of 270 patients is expected to conclude in October, ...
Canon has seen its business consistently deteriorate since its peak in 2007. With the pandemic highlighting its fundamental weaknesses further, the shares are a sell. With office equipment demand falling and cameras on a continued decline, the core earnings drivers will be unable to m...
Citing government sources, Kyodo News reports that Japanese health authorities have found it difficult to conclude the effectiveness of the anti-viral drug, Avigan, developed by Fujifilm Toyama Chemical Co., a unit of Fujifilm Holdings (FUJIF).The findings by the Pharmaceuticals and Medical D...
Dosing is underway in a Phase 3 clinical trial, PRESECO, evaluating Appili Therapeutics' (APLIF) Avigen tablets (favipiravir) for the treatment of COVID-19 patients with mild-to-moderate symptoms. The goal is to alleviate the symptoms and prevent disease progression.Enrollment target is ~826 ...
Mylan N.V. (NASDAQ: MYL ) and collaboration partner Fujifilm Kyowa Kirin Biologics Co., Ltd. ( OTCPK:FUJIF ) announce the FDA nod for Hulio (adalimumab-fkjp), a biosimilar to AbbVie's (NYSE: ABBV ) top seller Humira. More news on: Mylan, Inc., FUJIFILM Holdings Corporation, AbbVie Inc., ...
Fujifilm Holdings ( OTCPK:FUJIF ) partners with Dr. Reddy's Laboratories (NYSE: RDY ) and Global Response Aid (GRA) for the development, manufacture and sales of Avigan Tablets (favipiravir), an influenza drug developed by its unit, for a potential treatment of COVID-19. More n...
The value of proper clinical trials is that they give results that give confidence in the efficacy (or otherwise) of drugs. The UK has a complex major trial (RECOVERY) for testing drugs for treating COVID-19. Recent results from this trial were pivotal in the FDA deciding that hydroxychloro...
Russia's Ministry of Health has approved an off-patent pill, originally sold under the brand name Avigan for influenza by a unit of Fujifilm Holdings ( OTCPK:FUJIF ), for the treatment of hospitalized COVID-19 patients. More news on: FUJIFILM Holdings Corporation, Gilead Sciences, Inc., ...
News, Short Squeeze, Breakout and More Instantly...
FUJIFILM Holdings Corp Company Name:
FUJIF Stock Symbol:
OTCMKTS Market:
The presented market story on the Industrial Microfiltration Market announced via Market.us is a comprehensive analysis of the leading parameters that are likely to determine the growth of the industrial microfiltration market in the forthcoming decade. Further, the study dives in deep to exam...
New York City, NY: March 16, 2020 - Published via (Wired Release) - Recent Research and Future Market Potential of Gastroscopes Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information relate...
New York City, NY: March 19, 2020 - Published via (Wired Release) - Recent Research and Future Market Potential of Gastrointestinal Endoscopy Devices Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates ...